HC Wainwright Issues Optimistic Outlook for Insmed Earnings
Insmed Incorporated (NASDAQ:INSM – Free Report) – Research analysts at HC Wainwright lifted their Q2 2025 earnings estimates for Insmed in a research report issued on Monday, May 12th. HC Wainwright analyst A. Fein now forecasts that the biopharmaceutical company will post earnings of ($1.28) per share for the quarter, up from their prior forecast […]
Insmed Incorporated (NASDAQ:INSM – Free Report) – Research analysts at HC Wainwright lifted their Q2 2025 earnings estimates for Insmed in a research report issued on Monday, May 12th. HC Wainwright analyst A. Fein now forecasts that the biopharmaceutical company will post earnings of ($1.28) per share for the quarter, up from their prior forecast […]
